- Report
- August 2022
- 118 Pages
Global
From €4275EUR$4,500USD£3,666GBP
- Report
- February 2019
Global
From €4275EUR$4,500USD£3,666GBP
- Report
- October 2021
- 115 Pages
Global
From €4228EUR$4,450USD£3,625GBP
- Report
- April 2020
- 116 Pages
Global
From €3477EUR$3,660USD£2,982GBP
- Report
- April 2020
- 117 Pages
Global
From €3477EUR$3,660USD£2,982GBP
- Report
- April 2020
- 80 Pages
United States
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 83 Pages
Pakistan
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 85 Pages
Bulgaria
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 84 Pages
Russia
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 84 Pages
Switzerland
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 81 Pages
Turkey
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 82 Pages
Italy
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 80 Pages
Brazil
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 88 Pages
Canada
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 87 Pages
Peru
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 82 Pages
Argentina
From €2565EUR$2,700USD£2,200GBP
- Report
- April 2020
- 85 Pages
Belgium
From €2565EUR$2,700USD£2,200GBP
- Report
- November 2022
- 82 Pages
Europe
From €1425EUR$1,500USD£1,222GBP
- Drug Pipelines
- October 2020
- 140 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Drug Pipelines
- November 2020
- 108 Pages
Global
From €1900EUR$2,000USD£1,629GBP
The Hospital Acquired Infection (HAI) market is a subset of the Infectious Diseases Drugs market. HAIs are infections that occur in a hospital setting, and can be caused by a variety of bacteria, viruses, and fungi. These infections can be difficult to treat, as they are often resistant to antibiotics. As such, HAI drugs are designed to target specific pathogens, and are often used in combination with other treatments.
The HAI market is driven by the increasing prevalence of antibiotic-resistant infections, as well as the need for more effective treatments. Additionally, the rising number of hospitalizations due to chronic illnesses has also contributed to the growth of the market.
Some of the major players in the HAI market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, and Johnson & Johnson. These companies are actively developing new drugs and treatments to address the growing prevalence of HAIs. Show Less Read more